Expertise in
12
conditions

Dr. Christopher C. Striebich

Rheumatology
University Physicians Incorporated
12605 E 16th Ave, Uchealth Anschutz Medical, 
Aurora, CO 
Accepting New Patients
Offers Telehealth
Expertise in
12
conditions
University Physicians Incorporated
12605 E 16th Ave, Uchealth Anschutz Medical, 
Aurora, CO 

Overview

Christopher Striebich is a Rheumatologist in Aurora, Colorado. Dr. Striebich is highly rated in 12 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Necrotizing Vasculitis, Juvenile Temporal Arteritis, and Giant Cell Arteritis (GCA). Dr. Striebich is currently accepting new patients.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Rheumatology

Licenses

Internal Medicine in CO

Hospital Affiliations

Uch-Memorial Health System
University Of Colorado Hospital Authority

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Rocky Mountain Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

UNIVERSITY PHYSICIANS INCORPORATED
12605 E 16th Ave, Uchealth Anschutz Medical, Aurora, CO 80045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain a Serum Uric Acid Response
A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain a Serum Uric Acid Response
Enrollment Status: Completed
Publish Date: June 27, 2024
Intervention Type: Drug, Biological
Study Drug: Pegloticase
Study Phase: Phase 4
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Drug
Study Drug: TAK-079
Study Phase: Phase 1
A Multi-center, Randomized, Double-blinded, Placebo-controlled, Multiple-ascending-dose Study of Brentuximab Vedotin in Adults With Active Systemic Lupus Erythematosus
A Multi-center, Randomized, Double-blinded, Placebo-controlled, Multiple-ascending-dose Study of Brentuximab Vedotin in Adults With Active Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: June 11, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

20 Total Publications

Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation.
Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation.
Journal: Science translational medicine
Published: September 24, 2025
Similar Doctors
Expertise in
6
conditions
Dr. Kevin Deane
Rheumatology
Expertise in
6
conditions
Dr. Kevin Deane
Rheumatology

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (0.2 miles away)
720-848-7700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kevin Deane is a Rheumatologist in Aurora, Colorado. Dr. Deane is highly rated in 6 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Rheumatoid Lung Disease, and Synovitis.

Expertise in
18
conditions
Dr. Jason Kolfenbach
Rheumatology
Expertise in
18
conditions
Dr. Jason Kolfenbach
Rheumatology

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (0.2 miles away)
720-848-7700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jason Kolfenbach is a Rheumatologist in Aurora, Colorado. Dr. Kolfenbach is highly rated in 18 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis, Juvenile Temporal Arteritis, and Temporal Arteritis.

Expertise in
4
conditions
Dr. David Collier
Rheumatology
Expertise in
4
conditions
Dr. David Collier
Rheumatology

University Of Colorado Hospital

1665 Aurora Ct Fl 2, 
Aurora, CO 
 (0.4 miles away)
720-848-0000
Languages Spoken:
English

David Collier is a Rheumatologist in Aurora, Colorado. Dr. Collier is highly rated in 4 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Psoriatic Arthritis, and Psoriasis.

Frequently Asked Questions about Dr. Christopher C. Striebich

How do I make an appointment with Dr. Christopher C. Striebich?

You can book an appointment with Dr. Christopher C. Striebich by calling their office at 720-848-0000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Christopher C. Striebich a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher C. Striebich is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Christopher C. Striebich specialize in?

While Dr. Christopher C. Striebich is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Necrotizing Vasculitis, and Juvenile Temporal Arteritis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Christopher C. Striebich participate in research or clinical trials?

Yes. Dr. Christopher C. Striebich has published 20 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Christopher C. Striebich's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Christopher C. Striebich accept my insurance?

Dr. Christopher C. Striebich accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 720-848-0000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Striebich's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 41 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile